Skip to menu Skip to content Skip to footer

2008

Conference Publication

Hepcidin regulation in response to alcohol consumption: evidence for an alcohol-induced hypoxic response

Heritage, M. L., Jaskowski, L. A., Bridle, K. R., Murphy, T. L., Anderson, G. J., Crawford, D. H. and Fletcher, L. M. (2008). Hepcidin regulation in response to alcohol consumption: evidence for an alcohol-induced hypoxic response. Australian Gastroenterology Week, Brisbane, Qld, Australia, 22-25 October, 2008. Carlton South, Vic, Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2008.05613.x

Hepcidin regulation in response to alcohol consumption: evidence for an alcohol-induced hypoxic response

2008

Conference Publication

Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levels

Popa, C., Bridle, K. R., Morgan, M. L., Clouston, A. D., Fletcher, L. M. and Crawford, D. H. G. (2008). Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levels. 43rd Annual Meeting of the European Association for the Study of the Liver, Milan, Italy, 23-27 April, 2008. Ireland: Elsevier. doi: 10.1016/S0168-8278(08)60467-5

Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levels

2008

Conference Publication

Multiple pathways to hepatic fibrosis are inhibited by rapamycin

Bridle, K. R., Sobbe, A. L., Fletcher, L. M., Clouston, A. D. and Crawford, D. H. G. (2008). Multiple pathways to hepatic fibrosis are inhibited by rapamycin. Australian Gastroenterology Week 2008, Brisbane, Qld, Australia, 22-25 October 2008. Carlton South, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2008.05613.x

Multiple pathways to hepatic fibrosis are inhibited by rapamycin

2007

Conference Publication

Rapamycin as an anti-fibrotic agent

Popa, C., Bridle, K. R., Morgan, M. L., Robinson, M. W., Fletcher, L. M. and Crawford, D. H. (2007). Rapamycin as an anti-fibrotic agent. Australian Gastroenterology Week, Perth, Australia, 24-27 October 2007. Australia. doi: 10.1111/j.1440-1746.2007.05161.x

Rapamycin as an anti-fibrotic agent

2007

Conference Publication

Hepciden gene expression is further suppressed in Hfe-/- mice following chronic ethanol consumption

Fletcher, L. M., Heritage, M. L., Murphy, T. L., Bridle, K. R., Anderson, G. J. and Crawford, D. H. G. (2007). Hepciden gene expression is further suppressed in Hfe-/- mice following chronic ethanol consumption. 2007 International BioIron Society Meeting, Kyoto, Japan, 1-6 April, 2007. New York: Wiley-LISS. doi: 10.1002/ajh.20964

Hepciden gene expression is further suppressed in Hfe-/- mice following chronic ethanol consumption

2007

Conference Publication

Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis

Fletcher, L. M., Heritage, M. L., Murphy, T. L., Popa, C., Bridle, K. R., Anderson, G. J. and Crawford, D. H. (2007). Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis. 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Massachusetts, U.S.A., 1-6 November 2007. U.S.A.: Wiley InterScience. doi: 10.1002/hep.22022

Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis

2007

Conference Publication

Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis

Heritage, M. L., Murphy, T. L., Popa, C., Bridle, K. R., Anderson, G. J., Crawford, D. H. G. and Fletcher, L. M. (2007). Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis. Australian Gastroenterology Week 2007, Perth, Australia, 24–27 October 2007. Melbourne, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2007.05161.x

Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis

2006

Conference Publication

Very low dose rapamycin : In vitro evidence for its use as an antifibrotic agent

Morgan, M. L., Bridle, K. R., Fletcher, L. M. and Crawford, D. H. G. (2006). Very low dose rapamycin : In vitro evidence for its use as an antifibrotic agent. Australian Gastroenterology Week, Adelaide, SA, Australia, 11-14 October 2006. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x

Very low dose rapamycin : In vitro evidence for its use as an antifibrotic agent

2006

Conference Publication

Serum adiponectin is increased in HFE-/- mice fed alcohol

Bridle, K. R., Murphy, T. L., Anderson, G. J., Macdonald, G. A., Crawford, D. H. G. and Fletcher, L. M. (2006). Serum adiponectin is increased in HFE-/- mice fed alcohol. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x

Serum adiponectin is increased in HFE-/- mice fed alcohol

2006

Conference Publication

Very low dose rapamycin: in vitro evidence for its use as an antifibrotic agent

Morgan, M. L., Bridle, K. R., Fletcher, L. M. and Crawford, D. H. G. (2006). Very low dose rapamycin: in vitro evidence for its use as an antifibrotic agent. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x

Very low dose rapamycin: in vitro evidence for its use as an antifibrotic agent

2006

Conference Publication

Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis

Bridle, K. R., Patella, S., Tchongue, J., Fletcher, L. M., Sievert, W. and Crawford, D. H. G. (2006). Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x

Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis

2006

Conference Publication

Post liver transplantation disease recurrence: influence of matrix degradation proteins

Bridle, K. R., Murphy, T. L., Fletcher, L. M. and Crawford, D. H. G. (2006). Post liver transplantation disease recurrence: influence of matrix degradation proteins. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x

Post liver transplantation disease recurrence: influence of matrix degradation proteins

2006

Conference Publication

Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis

Bridle, K. R., Patella, S., Tchongue, J., Fletcher, L. M., Sievert, W. and Crawford, D. H. G. (2006). Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis. Australian Gastroenterology Week, Adelaide, Australia, 11–14 October 2006. Oxford United Kingdom: Wiley.

Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis

2005

Conference Publication

Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease

Anderson, Greg, Frazer, David M., Bridle, Kim R., Macdonald, Graeme A., Smith, Jeffrey L., Turlin, Bruno, Subramaniam, Nathan, Crawford, Darrell H., Powell, Lawrie W. and Ramm, Grant A. (2005). Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease. 47th Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, 10-13 December, 2005. Washington, D.C., USA: American Society of Hematology.

Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease

2005

Conference Publication

Rapamycin, but not cyclosporine A or tacrolimus, reduces hepatic stellate cell activation: implications for post-transplant fibrogenesis

Bridle, K. R., Robinson, M. W., Fletcher, L. M. and Crawford, D. H. (2005). Rapamycin, but not cyclosporine A or tacrolimus, reduces hepatic stellate cell activation: implications for post-transplant fibrogenesis. Australian Gastroenterology Week 2005, Brisbane, Qld, Australia, 19-22 October, 2005. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2005.04091_4.x

Rapamycin, but not cyclosporine A or tacrolimus, reduces hepatic stellate cell activation: implications for post-transplant fibrogenesis

2005

Conference Publication

Optimising conditions for assessing glucose output from isolated rat hepatocytes in response to insulin

Stephenson, M. D., Bridle, K. R., Whitehead, J. P. and Macdonald, G. A. (2005). Optimising conditions for assessing glucose output from isolated rat hepatocytes in response to insulin. Australian Gastroenterology Week 2005, Brisbane, Qld, Australia, 19-22 October, 2005. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2005.04091_4.x

Optimising conditions for assessing glucose output from isolated rat hepatocytes in response to insulin

2004

Conference Publication

Alcohol-induced downregulation of hepcidin mRNA expression is mediated by oxidative stress

Bridle, Kim, Crawford, Darrell, Fletcher, Linda, Murphy, Therese and Walters, Margaret (2004). Alcohol-induced downregulation of hepcidin mRNA expression is mediated by oxidative stress. The Liver Meeting 2004: 55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, MA, U.S.A., 29 October-2 November 2004. Hoboken, NJ, U.S.A: John Wiley & Sons. doi: 10.1002/hep.1840400508

Alcohol-induced downregulation of hepcidin mRNA expression is mediated by oxidative stress

2004

Conference Publication

Factors affecting the gene expression of hepcidin in chronic viral hepatitis C

Bridle, K. R., Fletcher, L. M., Jonsson, J. R., Richardson, M. M., Clouston, A. D., Powell, E. E. and Crawford, D. H. G. (2004). Factors affecting the gene expression of hepcidin in chronic viral hepatitis C. Australian Gastroenterology Week 2004, Brisbane Convention Centre, Brisbane, Qld Australia, 4-8 October, 2004. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2004.3615_3..x

Factors affecting the gene expression of hepcidin in chronic viral hepatitis C

2004

Conference Publication

Alcohol-induced downregulation of hepcidin mRNA expression is mediated by oxidative stress

Bridle, K., Murphy, T., Walters, M., Crawford, D. and Fletcher, L. (2004). Alcohol-induced downregulation of hepcidin mRNA expression is mediated by oxidative stress. 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Boston MA, United States, Oct 29 - Nov 02 2004. Hoboken, NJ United States: John Wiley & Sons.

Alcohol-induced downregulation of hepcidin mRNA expression is mediated by oxidative stress

2004

Conference Publication

Alcohol-induced down-regulation of hepcidin mRNA expression is mediated by oxidative stress

Bridle, K. R., Murphy, T., Walters, M., Crawford, D. H. G. and Fletcher, L. M. (2004). Alcohol-induced down-regulation of hepcidin mRNA expression is mediated by oxidative stress. Australian Gastroenterology Week 2004, Brisbane Convention Centre, Brisbane Qld, Australia, 4-8 October, 2004. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2004.3615_3..x

Alcohol-induced down-regulation of hepcidin mRNA expression is mediated by oxidative stress